Patient-reported outcome measures improve survival risk and quality of life for cancer patients, according to a study published Aug. 13 in JAMA Network Open. PROMs are self-reported statements from ...

Incorporating patient-reported outcome measures, such as quality of life, as well as looking into real-world data, is ...

Providing the best patient-centered care, as measured by the individual patient's perceived value of care at a reasonable cost, has become the established definition of value-based health care (VBHC).

ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results Patients diagnosed with hereditary RC are more prone to ...

A new policy review published in The Lancet Oncology and led by Ian Tannock and Madeline Pe, together with an international team of oncologists, statisticians, patients and patient-reported outcomes ...

Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...

Please provide your email address to receive an email when new articles are posted on . CMS established a policy to standardize PROMs collection and reporting. There are several barriers to PROMs data ...

Patient-reported outcome measures (PROMs) are crucial tools for assessing the health and well-being of children, yet their application in pediatrics faces unique challenges due to developmental ...

This is a preview. Log in through your library . Abstract Purpose Patient-reported outcome measures (PROMs) are standardized instruments used to collect data about the subjective assessment of medical ...

Implementation of a Novel Pathway to Integrate Palliative and Oncology Care for Patients With Acute Myeloid Leukemia in a Community Hospital Patient-reported outcome measures (PROMs) provide a direct ...

Please provide your email address to receive an email when new articles are posted on . More than 70% of patients requesting assistance identified as African American. Patients who received assistance ...

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...